1258 related articles for article (PubMed ID: 24258426)
1. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
[TBL] [Abstract][Full Text] [Related]
2. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
Lancé MD; Ninivaggi M; Schols SE; Feijge MA; Oehrl SK; Kuiper GJ; Nikiforou M; Marcus MA; Hamulyak K; van Pampus EC; ten Cate H; Heemskerk JW
Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
[TBL] [Abstract][Full Text] [Related]
3. The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry.
Ogawa S; Szlam F; Bolliger D; Nishimura T; Chen EP; Tanaka KA
Anesth Analg; 2012 Jul; 115(1):16-21. PubMed ID: 22467887
[TBL] [Abstract][Full Text] [Related]
4. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery.
Schols SE; Lancé MD; Feijge MA; Damoiseaux J; Marcus MA; Hamulyák K; Ten Cate H; Heemskerk JW; van Pampus EC
Thromb Haemost; 2010 Feb; 103(2):318-28. PubMed ID: 20024495
[TBL] [Abstract][Full Text] [Related]
5. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
[TBL] [Abstract][Full Text] [Related]
6. Normalization of blood clotting characteristics using prothrombin complex concentrate, fibrinogen and FXIII in an albumin based fluid: experimental studies in thromboelastometry.
Koller T; Kinast N; Castellanos AG; Garcia SP; Iglesias PP; Vintro XL; Arranz JM; Seto NV; García MVM; Moreno-Castaño AB; Aznar-Salatti J; Albaladejo GE; Diaz-Ricart M
Scand J Trauma Resusc Emerg Med; 2021 Apr; 29(1):57. PubMed ID: 33836790
[TBL] [Abstract][Full Text] [Related]
7. Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery.
Solomon C; Rahe-Meyer N; Sørensen B
Thromb Res; 2011 Sep; 128(3):277-82. PubMed ID: 21429567
[TBL] [Abstract][Full Text] [Related]
8. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry.
Brinkman AC; Romijn JW; van Barneveld LJ; Greuters S; Veerhoek D; Vonk AB; Boer C
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):422-6. PubMed ID: 20056447
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.
De Lorenzo C; Calatzis A; Welsch U; Heindl B
Anesth Analg; 2006 Apr; 102(4):1194-200. PubMed ID: 16551923
[TBL] [Abstract][Full Text] [Related]
11. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
[TBL] [Abstract][Full Text] [Related]
12. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients.
Solomon C; Cadamuro J; Ziegler B; Schöchl H; Varvenne M; Sørensen B; Hochleitner G; Rahe-Meyer N
Transfusion; 2011 Aug; 51(8):1695-706. PubMed ID: 21352237
[TBL] [Abstract][Full Text] [Related]
13. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery.
Ogawa S; Szlam F; Chen EP; Nishimura T; Kim H; Roback JD; Levy JH; Tanaka KA
Transfusion; 2012 Jan; 52(1):14-22. PubMed ID: 21756263
[TBL] [Abstract][Full Text] [Related]
14. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
Nielsen VG
Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
[TBL] [Abstract][Full Text] [Related]
15. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model.
Bolliger D; Szlam F; Molinaro RJ; Rahe-Meyer N; Levy JH; Tanaka KA
Br J Anaesth; 2009 Jun; 102(6):793-9. PubMed ID: 19420005
[TBL] [Abstract][Full Text] [Related]
16. High-dose fibrinogen versus a clinically recommended dose of fresh frozen plasma for reversal of dilutional coagulopathy in an in vitro model of severe hemodilution.
Rosenthal C; Rau J; Volk T; Sander M; Ziemer S; Von Heymann C
Minerva Anestesiol; 2014 Aug; 80(8):894-903. PubMed ID: 24398441
[TBL] [Abstract][Full Text] [Related]
17. High haematocrit in cyanotic congenital heart disease affects how fibrinogen activity is determined by rotational thromboelastometry.
Westbury SK; Lee K; Reilly-Stitt C; Tulloh R; Mumford AD
Thromb Res; 2013 Aug; 132(2):e145-51. PubMed ID: 23906940
[TBL] [Abstract][Full Text] [Related]
18. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
[TBL] [Abstract][Full Text] [Related]
19. Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin- activatable fibrinolysis inhibitor.
Shenkman B; Einav Y; Livnat T; Budnik I; Martinowitz U
Int J Lab Hematol; 2015 Aug; 37(4):521-9. PubMed ID: 25651468
[TBL] [Abstract][Full Text] [Related]
20. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
